423 related articles for article (PubMed ID: 25690476)
1. Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.
Burridge PW; Diecke S; Matsa E; Sharma A; Wu H; Wu JC
Methods Mol Biol; 2016; 1353():119-30. PubMed ID: 25690476
[TBL] [Abstract][Full Text] [Related]
2. Patient-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization of Cardiac Cells.
Zanella F; Sheikh F
Methods Mol Biol; 2016; 1353():147-62. PubMed ID: 25520292
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Human Pluripotent Stem Cells to Cardiomyocytes Under Defined Conditions.
van den Berg CW; Elliott DA; Braam SR; Mummery CL; Davis RP
Methods Mol Biol; 2016; 1353():163-80. PubMed ID: 25626427
[TBL] [Abstract][Full Text] [Related]
4. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
5. Generation and Characterization of Patient-Specific iPSC Model for Cardiovascular Disease.
Lee YK; Ran X; Lai KW; Lau VY; Siu DC; Tse HF
Methods Mol Biol; 2016; 1353():191-213. PubMed ID: 26126449
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
7. Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes.
Egashira T; Yuasa S; Tohyama S; Kuroda Y; Suzuki T; Seki T; Fukuda K
Methods Mol Biol; 2016; 1353():343-53. PubMed ID: 25520287
[TBL] [Abstract][Full Text] [Related]
8. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
9. Generation of Integration-Free Patient Specific iPS Cells Using Episomal Plasmids Under Feeder Free Conditions.
Caxaria S; Arthold S; Nathwani AC; Goh PA
Methods Mol Biol; 2016; 1353():355-66. PubMed ID: 25701132
[TBL] [Abstract][Full Text] [Related]
10. Defining optimal enzyme and matrix combination for replating of human induced pluripotent stem cell-derived cardiomyocytes at different levels of maturity.
Koc A; Sahoglu Goktas S; Akgul Caglar T; Cagavi E
Exp Cell Res; 2021 Jun; 403(2):112599. PubMed ID: 33848551
[TBL] [Abstract][Full Text] [Related]
11. Signature of circular RNAs in human induced pluripotent stem cells and derived cardiomyocytes.
Lei W; Feng T; Fang X; Yu Y; Yang J; Zhao ZA; Liu J; Shen Z; Deng W; Hu S
Stem Cell Res Ther; 2018 Mar; 9(1):56. PubMed ID: 29523209
[TBL] [Abstract][Full Text] [Related]
12. Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells.
Shoji E; Woltjen K; Sakurai H
Methods Mol Biol; 2016; 1353():89-99. PubMed ID: 25971915
[TBL] [Abstract][Full Text] [Related]
13. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
14. Calcium Imaging in Pluripotent Stem Cell-Derived Cardiac Myocytes.
Walter A; Šarić T; Hescheler J; Papadopoulos S
Methods Mol Biol; 2016; 1353():131-46. PubMed ID: 26025623
[TBL] [Abstract][Full Text] [Related]
15. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
[TBL] [Abstract][Full Text] [Related]
16. The impact of growth factors on human induced pluripotent stem cells differentiation into cardiomyocytes.
Yassa ME; Mansour IA; Sewelam NI; Hamza H; Gaafar T
Life Sci; 2018 Mar; 196():38-47. PubMed ID: 29337067
[TBL] [Abstract][Full Text] [Related]
17. Generation of Human Induced Pluripotent Stem Cells and Differentiation into Cardiomyocytes.
Han L; Mich-Basso J; Kühn B
Methods Mol Biol; 2021; 2158():125-139. PubMed ID: 32857370
[TBL] [Abstract][Full Text] [Related]
18. Transgene-Free Disease-Specific iPSC Generation from Fibroblasts and Peripheral Blood Mononuclear Cells.
Fidan K; Ebrahimi A; Çağlayan ÖH; Özçimen B; Önder TT
Methods Mol Biol; 2016; 1353():215-31. PubMed ID: 26126451
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial Disease-Specific Induced Pluripotent Stem Cell Models: Generation and Characterization.
Zhang X; Li S; Yang W; Pan H; Qin D; Zhu X; Yan Q
Methods Mol Biol; 2016; 1353():323-42. PubMed ID: 25646615
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
